Contemporary Considerations for Risk Stratification, Sudden Death and Prevention in Hypertrophic Cardiomyopathy

Overview

Journal Heart

Date 2003 Aug 19

PMID 12922995

Citations 5

Authors

B J Maron

Affiliations

Soon will be listed here.

Citing Articles

Echocardiography as a Screening Test for Myocardial Scarring in Children with Hypertrophic Cardiomyopathy.

Compton G, Nield L, Dragulescu A, Benson L, Grosse-Wortmann L Int J Pediatr. 2016; 2016:1980636.

PMID: 27974896 PMC: 5126423. DOI: 10.1155/2016/1980636.

Sudden cardiac arrest in apical hypertrophic cardiomyopathy.

Ahmed I, Smalley S, Zhu D, Dahiya R, House C, Nelson W BMJ Case Rep. 2011; 2009.

PMID: 21894248 PMC: 3027893. DOI: 10.1136/bcr.04.2009.1753.

ESCAPE-HCM study: Evaluation of SCreening of Asymptomatic PatiEnts with Hypertrophic CardioMyopathy.

Christiaans I, Dijksman L, Birnie E Neth Heart J. 2007; 15(6):216-20.

PMID: 17612686 PMC: 1896144. DOI: 10.1007/BF03085983.

Implications of arrhythmias and prevention of sudden death in hypertrophic cardiomyopathy.

Adabag A, Maron B Ann Noninvasive Electrocardiol. 2007; 12(2):171-80.

PMID: 17593187 PMC: 6932420. DOI: 10.1111/j.1542-474X.2007.00157.x.

Sudden cardiac death in athletes.

Hedrich O, Estes 3rd N, Link M Curr Cardiol Rep. 2006; 8(5):316-22.

PMID: 16956445 DOI: 10.1007/s11886-006-0069-z.

References

Butera G, Bonnet D, Kachaner J, Sidi D, Villain E . Heart rate variability in children with hypertrophic cardiomyopathy. Heart. 2003; 89(2):205-6. PMC: 1767526. DOI: 10.1136/heart.89.2.205. View

Ackerman M, VanDriest S, Ommen S, Will M, Nishimura R, Tajik A . Prevalence and age-dependence of malignant mutations in the beta-myosin heavy chain and troponin T genes in hypertrophic cardiomyopathy: a comprehensive outpatient perspective. J Am Coll Cardiol. 2002; 39(12):2042-8. DOI: 10.1016/s0735-1097(02)01900-9. View

Wigle E, Rakowski H, Kimball B, Williams W . Hypertrophic cardiomyopathy. Clinical spectrum and treatment. Circulation. 1995; 92(7):1680-92. DOI: 10.1161/01.cir.92.7.1680. View

Maron B, Shirani J, Poliac L, Mathenge R, Roberts W, Mueller F . Sudden death in young competitive athletes. Clinical, demographic, and pathological profiles. JAMA. 1996; 276(3):199-204. View

TEARE D . Asymmetrical hypertrophy of the heart in young adults. Br Heart J. 1958; 20(1):1-8. PMC: 492780. DOI: 10.1136/hrt.20.1.1. View

Maron B, Shen W, Link M, EPSTEIN A, Almquist A, Daubert J . Efficacy of implantable cardioverter-defibrillators for the prevention of sudden death in patients with hypertrophic cardiomyopathy. N Engl J Med. 2000; 342(6):365-73. DOI: 10.1056/NEJM200002103420601. View

Watkins H . Sudden death in hypertrophic cardiomyopathy. N Engl J Med. 2000; 342(6):422-4. DOI: 10.1056/NEJM200002103420609. View

Spirito P, BELLONE P, Harris K, Bernabo P, Bruzzi P, Maron B . Magnitude of left ventricular hypertrophy and risk of sudden death in hypertrophic cardiomyopathy. N Engl J Med. 2000; 342(24):1778-85. DOI: 10.1056/NEJM200006153422403. View

Maron B, Olivotto I, Spirito P, Casey S, BELLONE P, Gohman T . Epidemiology of hypertrophic cardiomyopathy-related death: revisited in a large non-referral-based patient population. Circulation. 2000; 102(8):858-64. DOI: 10.1161/01.cir.102.8.858. View

10.

Camm A, Nisam S . The utilization of the implantable defibrillator--a European enigma. Eur Heart J. 2000; 21(24):1998-2004. DOI: 10.1053/euhj.2000.2473. View

11.

Elliott P, Poloniecki J, Dickie S, Sharma S, Monserrat L, Varnava A . Sudden death in hypertrophic cardiomyopathy: identification of high risk patients. J Am Coll Cardiol. 2000; 36(7):2212-8. DOI: 10.1016/s0735-1097(00)01003-2. View

12.

Maron B, Leyhe 3rd M, Casey S, Gohman T, Lawler C, Crow R . Assessment of QT dispersion as a prognostic marker for sudden death in a regional nonreferred hypertrophic cardiomyopathy cohort. Am J Cardiol. 2001; 87(1):114-5, A9. DOI: 10.1016/s0002-9149(00)01285-6. View

13.

Elliott P, Gimeno Blanes J, Mahon N, Poloniecki J, McKenna W . Relation between severity of left-ventricular hypertrophy and prognosis in patients with hypertrophic cardiomyopathy. Lancet. 2001; 357(9254):420-4. DOI: 10.1016/S0140-6736(00)04005-8. View

14.

Priori S, Aliot E, Blomstrom-Lundqvist C, Bossaert L, Breithardt G, Brugada P . Task Force on Sudden Cardiac Death of the European Society of Cardiology. Eur Heart J. 2001; 22(16):1374-450. DOI: 10.1053/euhj.2001.2824. View

15.

Maron B . Hypertrophic cardiomyopathy: a systematic review. JAMA. 2002; 287(10):1308-20. DOI: 10.1001/jama.287.10.1308. View

16.

McKenna W, Oakley C, Krikler D, Goodwin J . Improved survival with amiodarone in patients with hypertrophic cardiomyopathy and ventricular tachycardia. Br Heart J. 1985; 53(4):412-6. PMC: 481782. DOI: 10.1136/hrt.53.4.412. View